Product Information
DOXEPIN HCL 6 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $1.3716 per EA under NDC 59651084530. Its NADAC has been published 50 times since Oct 22, 2025.
FDA first approved this application on Jul 25, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
6 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651084530
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOXEPIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216041FDA Approved
7/25/2024
TE Code
AB
On Market Since
7/12/2025
Pharmacological Classes
Price Statistics
The NADAC for DOXEPIN HCL 6 MG TABLET has been published 50 times since Oct 22, 2025, and over the history we have for it it has declined 36.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3716 per EA |
|---|---|
| All-time high | $2.1557 (Nov 12, 2025) |
| All-time low | $1.3716 (Sep 23, 2026) |
| 52-week high | $2.1557 |
| 52-week low | $1.3716 |
| Median price | $1.6733 |
| Average price | $1.6952 |
| Largest weekly change | -8.1% (Nov 19, 2025) |
| Weeks tracked | 50 |
| Tracking since | Oct 22, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the DOXEPIN market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DOXEPIN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tricyclic Antidepressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOXEPIN HCL 6 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN HCL 6 MG TABLET, manufactured by Aurobindo Pharma Limited, is $1.3716 per EA (NDC 59651084530), effective Sep 30, 2026.
How has the price of DOXEPIN HCL 6 MG TABLET changed over time?
Over the history we have for it, the NADAC for DOXEPIN HCL 6 MG TABLET has declined 36.4%. It has been tracked across 50 weekly CMS publications since Oct 22, 2025.
What are the highest and lowest recorded NADAC prices for DOXEPIN HCL 6 MG TABLET?
Since Oct 22, 2025, the NADAC for DOXEPIN HCL 6 MG TABLET has ranged from a low of $1.3716 (Sep 23, 2026) to a high of $2.1557 (Nov 12, 2025), with a median of $1.6733 per EA.
Are there cheaper alternatives to DOXEPIN HCL 6 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of DOXEPIN HCL 6 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DOXEPIN HCL 6 MG TABLET?
DOXEPIN HCL 6 MG TABLET (NDC 59651084530) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.